Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sopharma AD (3JR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10140
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブルガリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposable products; and injection molded products. It also performs research and development and implementation activities catering to the areas of phytochemistry, chemistry and pharmacy. Its key product portfolio consists of carsil, tempalgin, tabex, tribestan, broncholitin, analgin, nivalin and methylprednisolone. Geographically, the company distributes its products in Poland, Russia, Ukraine, Turkey, Georgia, Serbia, Belarus and other countries. Sopharma is headquartered in Sofia, Bulgaria.

Sopharma AD (3JR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sopharma AD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sopharma AD, Pharmaceuticals & Healthcare, Deal Details 10
Acquisition 10
Sopharma Acquires Additional 15.14% Stake In Briz, Medical Products Distributor 10
Rompharma Acquires Additional 9% Stake In Sopharma For US$24.3 Million 11
Sopharma Plans To Sell Extab, Biopharma Company 12
Sopharma To Acquire Additional 50.01% Stake In Bulgarska Roza-Sevtopolis 13
Sopharma AD – Key Competitors 14
Sopharma AD – Key Employees 15
Sopharma AD – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Recent Developments 18
Product News 18
03/08/2017: Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference (“SRNT”) 18
02/20/2018: Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study 19
Clinical Trials 20
Nov 14, 2017: Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects 20
Oct 04, 2017: Achieve Announces Advancement of Cytisine Clinical Development Program 21
Aug 16, 2017: Achieve Announces Initiation of Cytisine Clinical Development Program 22
Aug 10, 2017: Achieve Announces FDA Acceptance of the Investigational New Drug Application for Cytisine as a Smoking Cessation Treatment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Sopharma AD, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Deals By Therapy Area, 2012 to YTD 2018 8
Sopharma AD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sopharma Acquires Additional 15.14% Stake In Briz, Medical Products Distributor 10
Rompharma Acquires Additional 9% Stake In Sopharma For US$24.3 Million 11
Sopharma Plans To Sell Extab, Biopharma Company 12
Sopharma To Acquire Additional 50.01% Stake In Bulgarska Roza-Sevtopolis 13
Sopharma AD, Key Competitors 14
Sopharma AD, Key Employees 15
Sopharma AD, Subsidiaries 16
Sopharma AD, Joint Venture 17

List of Figures
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qinetiq Group Plc:企業の戦略・SWOT・財務分析
    Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report Summary Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • New World Development Co Ltd (17):企業の財務・戦略的SWOT分析
    New World Development Co Ltd (17) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • General Atomics:企業の戦略・SWOT・財務情報
    General Atomics - Strategy, SWOT and Corporate Finance Report Summary General Atomics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enel Generacion Peru SAA (EDEGELC1):企業の財務・戦略的SWOT分析
    Summary Enel Generacion Peru SAA (Enel Generacion) a subsidiary of Enel Americas SA, is a power generation company. It offers transmission and distribution of electricity. The company generates electricity through thermal and hydroelectric sources. It also carries out hydroelectric plant generation …
  • Biogen, Inc.:企業のM&A・事業提携・投資動向
    Biogen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Biogen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • BrightPath Early Learning Inc.:企業の戦略的SWOT分析
    BrightPath Early Learning Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • DTE Energy Co (DTE)-石油・ガス分野:企業M&A・提携分析
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Abaxis Inc:企業の戦略的SWOT分析
    Abaxis Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Gran Tierra Energy Inc (GTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …
  • Care UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Care UK Ltd (Care UK) is a healthcare service provider that offers clinical and social care services. The company’s healthcare services include treatment centres, General Practitioner(GP) practices, NHS walk-in centres, GP out-of-hours, prison health services, clinical assessment, diagnostic …
  • Petoro AS-石油・ガス分野:企業M&A・提携分析
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Perseus Mining Limited:企業の戦略・SWOT・財務情報
    Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Prudential Financial Inc:戦略・SWOT・企業財務分析
    Prudential Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Prudential Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Eddie Stobart Logistics plc:企業の戦略・SWOT・財務情報
    Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sublimity Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sublimity Therapeutics Ltd(Sublimity) formerly known as Sigmoid Pharma Ltd, focuses on the development of therapeutics for unmet clinical needs in gastrointestinal and immunological diseases and disorders. The company’s product portfolio includes cyclosporine, oral vaccines, oral peptides an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆